A carregar...
Resected Pancreatic Cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant Chemotherapy
Lymphatic metastasis is a major determinant of the outcome of resected pancreatic cancer. Gemcitabine-based adjuvant chemotherapy can improve the outcome of resected pancreatic cancer. However, the efficacy of gemcitabine against pancreatic cancer stratified by nodal involvement is unclear. In this...
Na minha lista:
| Publicado no: | Cancer Control |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7153189/ https://ncbi.nlm.nih.gov/pubmed/32268796 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1073274820915947 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|